Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates.
Zom GG, Khan S, Britten CM, Sommandas V, Camps MG, Loof NM, Budden CF, Meeuwenoord NJ, Filippov DV, van der Marel GA, Overkleeft HS, Melief CJ, Ossendorp F.
Zom GG, et al. Among authors: meeuwenoord nj.
Cancer Immunol Res. 2014 Aug;2(8):756-64. doi: 10.1158/2326-6066.CIR-13-0223. Epub 2014 Apr 21.
Cancer Immunol Res. 2014.
PMID: 24950688